{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:56:28Z","timestamp":1781510188940,"version":"3.54.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006352","name":"Virginia and DK Ludwig Foundation Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006063","name":"Paul & Daisy Soros Fellowships for New Americans","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006063","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.tranon.2026.102711","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T04:16:31Z","timestamp":1772511391000},"page":"102711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development and characterization of anti-CXCR4 chimeric antigen receptor T cells"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2858-1443","authenticated-orcid":false,"given":"Gabriel","family":"Seir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9518-0731","authenticated-orcid":false,"given":"Quenton Rashawn","family":"Bubb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Sotillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca M.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2909-2669","authenticated-orcid":false,"given":"Agnieszka","family":"Czechowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2026.102711_bib0001","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.tranon.2026.102711_bib0002","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41408-019-0170-3","article-title":"Late relapse in acute myeloid leukemia (AML): clonal evolution or therapy-related leukemia?","volume":"9","author":"Yilmaz","year":"2019","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.tranon.2026.102711_bib0003","first-page":"1934","article-title":"Relapsed childhood T-cell acute lymphoblastic leukemia and lymphoblastic lymphoma","volume":"110","author":"Hughes","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/j.tranon.2026.102711_bib0004","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2014.59.1636","article-title":"Childhood acute lymphoblastic leukemia: progress through collaboration","volume":"33","author":"Pui","year":"2015","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.tranon.2026.102711_bib0005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3324\/haematol.2009.014274","article-title":"Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group","volume":"95","author":"Oriol","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.tranon.2026.102711_bib0006","series-title":"StatPearls","article-title":"Hematopoietic stem cell transplantation","author":"Khaddour","year":"2025"},{"key":"10.1016\/j.tranon.2026.102711_bib0007","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3389\/fimmu.2017.00496","article-title":"Graft-versus-leukemia effect following hematopoietic stem cell transplantation for leukemia","volume":"8","author":"Dickinson","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2026.102711_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01217","article-title":"The graft-versus-leukemia effect in AML","volume":"9","author":"Sweeney","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2026.102711_bib0009","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5045\/br.2023.2023152","article-title":"Treatment outcome and prognostic factors in relapsed pediatric acute myeloid leukemia","volume":"58","author":"Lee","year":"2023","journal-title":"Blood Res."},{"key":"10.1016\/j.tranon.2026.102711_bib0010","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1158\/2159-8290.CD-12-0548","article-title":"The basic principles of chimeric antigen receptor design","volume":"3","author":"Sadelain","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.tranon.2026.102711_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1188049","article-title":"From bench to bedside: the history and progress of CAR T cell therapy","volume":"14","author":"Mitra","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2026.102711_bib0012","first-page":"21","article-title":"CAR T-cell therapy: adverse events and management","volume":"10","author":"Adkins","year":"2019","journal-title":"J. Adv. Pract. Oncol."},{"key":"10.1016\/j.tranon.2026.102711_bib0013","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1182\/blood.2020009515","article-title":"Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy","volume":"138","author":"Wudhikarn","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.tranon.2026.102711_bib0014","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.beha.2006.10.005","article-title":"The leukemic stem cell","volume":"20","author":"Jordan","year":"2007","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.tranon.2026.102711_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.775128","article-title":"Leukemic stem cells: from Leukemic niche biology to treatment opportunities","volume":"12","author":"Marchand","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2026.102711_bib0016","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s12015-021-10308-6","article-title":"Acute myeloid leukemia stem cells: origin, characteristics, and clinical implications","volume":"18","author":"Long","year":"2022","journal-title":"Stem. Cell Rev. Rep."},{"key":"10.1016\/j.tranon.2026.102711_bib0017","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood.V128.22.26.26","article-title":"Role of CXCL12-expressing bone marrow populations in leukemic stem cell regulation","volume":"128","author":"Agarwal","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.tranon.2026.102711_bib0018","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s41417-021-00418-1","article-title":"Use of CAR T-cell for acute lymphoblastic leukemia (ALL) treatment: a review study","volume":"29","author":"Sheykhhasan","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.tranon.2026.102711_bib0019","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1182\/blood.2023022922","article-title":"The present and future of CAR T-cell therapy for adult B-cell ALL","volume":"145","author":"Rampotas","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.tranon.2026.102711_bib0020","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1182\/blood.2024024063","article-title":"Honing CAR T cells to tackle acute myeloid leukemia","volume":"145","author":"Haubner","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.tranon.2026.102711_bib0021","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40164-025-00651-6","article-title":"Breakthroughs of CAR T-cell therapy in acute myeloid leukemia: updates from ASH 2024","volume":"14","author":"Zhang","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.tranon.2026.102711_bib0022","article-title":"Development of multivalent CAR T cells as dual immunotherapy and conditioning agents","volume":"0","author":"Bubb","year":"2025","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.tranon.2026.102711_bib0023","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.2174\/0929867324666170830111531","article-title":"Targeting CXCL12\/CXCR4 axis in Tumor Immunotherapy","volume":"26","author":"Zhou","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.tranon.2026.102711_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040321","article-title":"Gene Expression Commons: an open platform for absolute Gene expression profiling","volume":"7","author":"Seita","year":"2012","journal-title":"PLOS ONE"},{"key":"10.1016\/j.tranon.2026.102711_bib0025","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2026.102711_bib0026","doi-asserted-by":"crossref","first-page":"369","DOI":"10.7150\/thno.21397","article-title":"Dual targeting of acute leukemia and supporting niche by CXCR4-Directed Theranostics","volume":"8","author":"Habringer","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.tranon.2026.102711_bib0027","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7150\/thno.101215","article-title":"CXCR4-directed endoradiotherapy with [177Lu]Pentixather added to total body irradiation for myeloablative conditioning in patients with relapsed\/refractory acute myeloid leukemia","volume":"15","author":"Braitsch","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.tranon.2026.102711_bib0028","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1158\/1078-0432.CCR-12-2333","article-title":"BMS-936564\/MDX-1338: a fully human anti-CXCR4 antibody induces apoptosis in vitro and shows antitumor activity in vivo in hematologic malignancies","volume":"19","author":"Kuhne","year":"2013","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.tranon.2026.102711_bib0029","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1158\/1078-0432.CCR-19-0647","article-title":"A phase ib\/II trial of the first-in-class anti-CXCR4 antibody Ulocuplumab in combination with Lenalidomide or Bortezomib plus Dexamethasone in relapsed multiple myeloma","volume":"26","author":"Ghobrial","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tranon.2026.102711_bib0030","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.3389\/fimmu.2018.02940","article-title":"Overcoming target driven fratricide for T cell therapy","volume":"9","author":"Breman","year":"2018","journal-title":"Front. Immunol"},{"key":"10.1016\/j.tranon.2026.102711_bib0031","article-title":"Targeted CD7 CAR T-cells for treatment of T-lymphocyte leukemia and lymphoma and acute myeloid leukemia: recent advances","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2026.102711_bib0032","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3390\/cancers16020334","article-title":"CD45-Directed CAR-T cells with CD45 knockout efficiently kill myeloid leukemia and lymphoma cells In vitro even after extended culture","volume":"16","author":"Harfmann","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.tranon.2026.102711_bib0033","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3324\/haematol.2010.029660","article-title":"Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemia","volume":"96","author":"Balgobind","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.tranon.2026.102711_bib0034","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1182\/blood-2011-10-382861","article-title":"Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children\u2019s Oncology Group study","volume":"119","author":"Kang","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.tranon.2026.102711_bib0035","unstructured":"GSE94669, 61 lymphoma cell lines gene expression profiles - OmicsDI. https:\/\/www.omicsdi.org\/dataset\/geo\/GSE94669."},{"key":"10.1016\/j.tranon.2026.102711_bib0036","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1158\/2643-3230.BCD-21-0049","article-title":"Integrative genomic analysis of pediatric myeloid-related acute leukemias identifies novel subtypes and prognostic indicators","volume":"2","author":"Fornerod","year":"2021","journal-title":"Blood Cancer Discov."},{"key":"10.1016\/j.tranon.2026.102711_bib0037","doi-asserted-by":"crossref","first-page":"D1138","DOI":"10.1093\/nar\/gkad993","article-title":"BloodSpot 3.0: a database of gene and protein expression data in normal and malignant haematopoiesis","volume":"52","author":"G\u00edslason","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tranon.2026.102711_bib0038","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the Cancer Cell Line Encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2026.102711_bib0039","series-title":"ggplot2: Elegant Graphics For Data Analysis","author":"Wickham","year":"2016"},{"key":"10.1016\/j.tranon.2026.102711_bib0040","doi-asserted-by":"crossref","unstructured":"Bailur, J.K. et al. Risk-associated alterations in marrow T cells in pediatric leukemia. JCI Insight 5, e140179.","DOI":"10.1172\/jci.insight.140179"},{"key":"10.1016\/j.tranon.2026.102711_bib0041","unstructured":"Integrating single-cell transcriptomic data across different conditions, technologies, and species | Nature Biotechnology. https:\/\/www.nature.com\/articles\/nbt.4096."},{"key":"10.1016\/j.tranon.2026.102711_bib0042","doi-asserted-by":"crossref","unstructured":"Korsunsky, I. et al. Fast, sensitive, and accurate integration of single cell data with Harmony. 461954 preprint at https:\/\/doi.org\/10.1101\/461954 (2018).","DOI":"10.1101\/461954"},{"key":"10.1016\/j.tranon.2026.102711_bib0043","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/s41467-022-28803-w","article-title":"Fully-automated and ultra-fast cell-type identification using specific marker combinations from single-cell transcriptomic data","volume":"13","author":"Ianevski","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tranon.2026.102711_bib0044","doi-asserted-by":"crossref","first-page":"D609","DOI":"10.1093\/nar\/gkae1010","article-title":"UniProt: the Universal protein knowledgebase in 2025","volume":"53","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.tranon.2026.102711_bib0045","author":"Kuhne","year":"2013","journal-title":"Human monoclonal antibodies that bind CXCR4"},{"key":"10.1016\/j.tranon.2026.102711_bib0046","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/nbt1088-1204","article-title":"A short polypeptide marker sequence useful for recombinant protein identification and purification","volume":"6","author":"Hopp","year":"1988","journal-title":"Bio\/Technology"},{"key":"10.1016\/j.tranon.2026.102711_bib0047","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nm.3838","article-title":"4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors","volume":"21","author":"Long","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.tranon.2026.102711_bib0048","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.3390\/ijms24032718","article-title":"CD123 a therapeutic target for acute myeloid leukemia and blastic plasmocytoid dendritic neoplasm","volume":"24","author":"Pelosi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2026.102711_bib0049","article-title":"Preclinical evaluation of CD70-specific CAR T cells targeting acute myeloid leukemia","volume":"14","author":"Wu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2026.102711_bib0050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12885-021-09116-5","article-title":"Targeting CD33 for acute myeloid leukemia therapy","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tranon.2026.102711_bib0051","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1182\/bloodadvances.2022008981","article-title":"CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from Germany","volume":"7","author":"Bader","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.tranon.2026.102711_bib0052","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/pbc.25410","article-title":"Characterization of CD22 expression in acute lymphoblastic leukemia","volume":"62","author":"Shah","year":"2015","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.tranon.2026.102711_bib0053","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1182\/blood-2008-06-164129","article-title":"CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy","volume":"112","author":"Dworzak","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.tranon.2026.102711_bib0054","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/cam4.1085","article-title":"Inhibition of CXCL12\/CXCR4 axis as a potential targeted therapy of advanced gastric carcinoma","volume":"6","author":"Xue","year":"2017","journal-title":"Cancer Med."},{"key":"10.1016\/j.tranon.2026.102711_bib0055","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1182\/blood-2017-01-761320","article-title":"CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies","volume":"130","author":"Gomes-Silva","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.tranon.2026.102711_bib0056","doi-asserted-by":"crossref","first-page":"10101","DOI":"10.1073\/pnas.0804286105","article-title":"CXCR4\u2013CCR5: a couple modulating T cell functions","volume":"105","author":"Contento","year":"2008","journal-title":"Proc. Natl. Acad. Sci"},{"key":"10.1016\/j.tranon.2026.102711_bib0057","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ceb.2013.11.011","article-title":"Endocytic trafficking of chemokine receptors","volume":"27","author":"Marchese","year":"2014","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.tranon.2026.102711_bib0058","first-page":"100","article-title":"Chimeric-antigen-receptor (CAR) T cells and the factors influencing their therapeutic efficacy","volume":"2","author":"Kravets","year":"2017","journal-title":"J. Immunol. Res. Ther."},{"key":"10.1016\/j.tranon.2026.102711_bib0059","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/cmi.2017.107","article-title":"The unique structural and functional features of CXCL12","volume":"15","author":"Janssens","year":"2018","journal-title":"Cell. Mol. Immunol."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326000483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326000483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:51:44Z","timestamp":1781509904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326000483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":59,"alternative-id":["S1936523326000483"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102711","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and characterization of anti-CXCR4 chimeric antigen receptor T cells","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102711","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102711"}}